CompletedNot Applicable

Triglyceride Rich Lipoproteins and Platelet Activation in Type 2 Diabetes

France32 participantsStarted 2018-10-15

Plain-language summary

To investigate in vitro the effect of triglyceride rich lipoproteins (TGRL) obtained in type 2 diabetic women in the fasting state and following a randomized isocaloric lipid rich breakfast on control human platelets Randomized Comparison of butter versus chocolate spread in 2 groups of 15 patients

Who can participate

Age range50 Years – 80 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Menopausal women * HbA1c ≥6,5 ou ≤10% * 27 ≤ BMI ≤40 kg/m2 Exclusion Criteria: * Insulin therapy * fibrates or Omega 3 fatty acids supplements * Hormonal replacement therapy of menopause * Glycemia \> 16 mmol/l * Alcohol abuse (≥3 Unit/day) * Special dietary habits * History of bariatric surgery

What they're measuring

fasting thromboxane B2 concentration

Timeframe: Hour 0

after breakfast thromboxane B2 concentration

Timeframe: 4 hours

Trial details

NCT IDNCT03561571

SponsorHospices Civils de Lyon

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-05-14

View on ClinicalTrials.gov More Type2 Diabetes trials